Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,256 | -3,100 | -1,664 | -7,933 | -6,444 |
| Depreciation Amortization | 65 | 43 | 21 | 24 | 19 |
| Accounts payable and accrued liabilities | -95 | -13 | -2 | -392 | -405 |
| Other Working Capital | 424 | 206 | 27 | -608 | -691 |
| Other Operating Activity | 219 | 108 | 52 | 665 | 620 |
| Operating Cash Flow | $-3,643 | $-2,756 | $-1,566 | $-8,244 | $-6,901 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 3,050 |
| PPE Investments | -2 | N/A | N/A | -4 | -4 |
| Sale Of Investment | N/A | N/A | N/A | 3,050 | N/A |
| Investing Cash Flow | $-2 | $N/A | $N/A | $3,046 | $3,046 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,281 | 6,517 | 3,081 | 3,532 | 3,532 |
| Other Financing Activity | -599 | -403 | -117 | -428 | -323 |
| Financing Cash Flow | $6,682 | $6,114 | $2,964 | $3,104 | $3,209 |
| Beginning Cash Position | 6,608 | 6,608 | 6,608 | 8,702 | 8,702 |
| End Cash Position | 9,645 | 9,966 | 8,006 | 6,608 | 8,056 |
| Net Cash Flow | $3,037 | $3,358 | $1,398 | $-2,094 | $-646 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,643 | -2,756 | -1,566 | -8,244 | -6,901 |
| Capital Expenditure | -2 | N/A | N/A | -4 | -4 |
| Free Cash Flow | -3,645 | -2,756 | -1,566 | -8,248 | -6,905 |